Morning Cortisol Levels Elevated in Frequent Cannabis Users, Oregon State University Study Finds

As cannabis legalization and social acceptance sweep across North America and global markets, public health researchers are shifting their focus from broad legislative impacts to the intricate, long-term neurobiological consequences of regular consumption. A recent empirical investigation conducted by scientists at Oregon State University (OSU) sheds new light on this evolving landscape, revealing that individuals who use cannabis frequently often begin their days with significantly higher baseline concentrations of cortisol compared to nonusers. Published in the peer-reviewed journal Cannabis, the study highlights a potential disruption to the human body’s circadian stress rhythm, offering a fresh lens through which scientists can view the physiological interplay between exogenous cannabinoids and the central nervous system.

Led by Dr. Anita Cservenka, an associate professor in the OSU College of Liberal Arts, alongside colleagues Julia Donner and Alexia Obrochta, the research ventures into uncharted territory. While millions of consumers routinely turn to cannabis as a pharmacological balm for anxiety, tension, and daily pressure, this research underscores a paradox: while the plant may offer acute, short-term relief from psychological stress, long-term frequent use may fundamentally interfere with the biological machinery designed to regulate the body’s natural response to environmental demands.

Understanding the Hypothalamic-Pituitary-Adrenal Axis

At the center of this investigation is the hypothalamic-pituitary-adrenal (HPA) axis, the body’s premier neuroendocrine command center. The HPA axis acts as a master regulator, orchestrating a cascade of hormonal signals between the hypothalamus in the brain, the pituitary gland, and the adrenal glands situated atop the kidneys. When an individual encounters a physical or psychological stressor, this axis activates, ultimately releasing glucocorticoids—principally cortisol—into the bloodstream.

Cortisol, frequently dubbed the "stress hormone," is essential for human survival. Beyond helping individuals navigate immediate challenges by mobilizing energy stores, elevating blood pressure, and sharpening focus, cortisol plays a foundational role in maintaining immunological health, metabolic regulation, and glucose homeostasis. Under normal physiological conditions, cortisol follows a predictable circadian rhythm. Levels are at their lowest around midnight, begin a steady climb in the early morning hours, peak sharply shortly after a person wakes up, and then gradually taper off throughout the afternoon and evening.

In the OSU study, the research team specifically targeted this morning surge, known scientifically as the cortisol awakening response (CAR). CAR is calculated by taking an initial saliva or blood sample immediately upon waking and a second sample exactly 30 minutes later. The resulting mathematical difference serves as a reliable biological indicator of how primed an individual’s nervous system is to tackle the demands of the day ahead.

Surprisingly, Cservenka and her team discovered that the magnitude of the CAR—the actual upward spike in cortisol from minute zero to minute thirty—was largely comparable between frequent cannabis users and nonusers. Where the divergence occurred was at the baseline. Frequent cannabis users already possessed elevated quantities of circulating cortisol the moment they opened their eyes. This elevated starting point suggests that the intrinsic daily rhythm governing stress adaptation may be chronically shifted or hyper-activated in those who consume cannabis regularly.

The Broader Epidemiological Landscape

The release of these findings coincides with a historic transformation in demographic patterns of cannabis consumption across the United States. Over the past fifteen years, shifting legal frameworks, commercialization, and destigmatization have catalyzed a massive surge in usage rates, particularly among young adults.

According to robust national epidemiological data referenced by the researchers, approximately 29 percent of adults aged 19 to 30 reported using cannabis within a previous 30-day window. This statistic represents a near-doubling of consumption prevalence within this age bracket over a decade and a half. More critically, the proportion of young adults engaging in high-frequency use has escalated dramatically. More than 10 percent of individuals in this cohort now report consuming cannabis at least 20 times within a 30-day timeframe—a frequency rate more than double what was recorded fifteen years ago.

This widespread mainstream integration of cannabis has left public health authorities scrambling to understand the long-term health implications. While decades of research have documented the acute psychological effects of tetrahydrocannabinol (THC) and cannabidiol (CBD), the chronic physiological footprints left by frequent use on endocrine and neuroendocrine pathways remain underexplored.

Methodological Nuances and Scientific Caution

In discussing the implications of their work, Dr. Cservenka and her co-authors exercise rigorous scientific caution, explicitly emphasizing the cross-sectional nature of the study. The findings do not establish a definitive causal arrow. Specifically, the data cannot confirm whether frequent cannabis use actively drives up morning cortisol levels, nor can it conclusively prove that individuals with inherently elevated morning cortisol are driven toward higher rates of cannabis consumption to self-medicate underlying physiological tension.

"We would need to study the same groups of people over a longer period of time to understand any cause-and-effect relationship, but we think this provides an important starting point," Cservenka noted. Longitudinal tracking—following cohorts of individuals over months and years as their consumption habits fluctuate—will be necessary to untangle the directionality of this relationship.

Furthermore, the OSU study adds a layer of complexity to a broader scientific debate regarding cannabis and cortisol. Previous studies conducted by independent research groups have occasionally reported blunted CAR responses among chronic cannabis users, characterizing the endocrine system as fatigued or desensitized by chronic cannabinoid exposure. The Oregon State team, however, did not replicate this blunting effect, observing instead the elevated baseline phenomenon.

Cservenka attributes these discrepancies to the inherent nuances of endocrinological research. Variations in analytic strategies, differences in participant sample characteristics, quantification methods, and the exact timelines of recent cannabis use among study participants can all yield divergent outcomes. This scientific friction highlights just how intricate the pharmacodynamics of cannabis truly are when interacting with the human endocrine architecture.

The Double-Edged Sword of Cortisol and Stress Management

To contextualize the importance of morning cortisol elevations, health experts point to the delicate balance required by the human endocrine system. While short bursts of cortisol are adaptive, protective, and essential for survival, chronic hypercortisolemia—sustained, long-term elevation of cortisol levels—carries substantial systemic risks.

Prolonged exposure to elevated cortisol has been clinically linked to a myriad of adverse health outcomes, including dysregulated metabolic syndrome, cardiovascular disease, hypertension, and cognitive impairment. Moreover, chronically altered cortisol rhythms are frequently observed in patients suffering from major depressive disorder, generalized anxiety disorders, and chronic fatigue syndromes.

This creates a potentially self-reinforcing feedback loop. If frequent cannabis use alters the circadian rhythm of cortisol in a way that elevates baseline stress hormones, users might experience a subtle, ongoing sense of internal tension or autonomic hyper-arousal. Because many individuals consciously or unconsciously turn to cannabis precisely to alleviate feelings of stress, anxiety, or jitteriness, this biological disruption could theoretically perpetuate a cycle: a dysregulated stress system generates discomfort, which prompts further cannabis consumption, which in turn reinforces the neuroendocrine alteration.

Toward a Neurobiological Marker of Problematic Use

Despite the need for further replication and longitudinal validation, the Oregon State University team believes their findings point toward a promising clinical horizon. Identifying objective, biological signatures of substance use patterns has long been a holy grail for addiction medicine and mental health professionals, who traditionally rely entirely on subjective self-reporting from patients.

"Our research suggests cortisol levels upon awakening may serve as a neurobiological marker of problematic cannabis use, and that connection needs to be investigated further," Cservenka stated. By establishing reliable physiological correlates associated with heavy consumption, clinicians may eventually gain better diagnostic tools to evaluate when casual or recreational use crosses the threshold into problematic or dependent patterns that warrant clinical intervention.

As the legal and cultural normalization of cannabis continues its rapid global expansion, studies of this nature provide essential counterweights to the narrative that the plant is entirely benign. The research bridges the gap between sociological trends in consumption and microscopic endocrinological realities, reminding policymakers, healthcare providers, and consumers alike that introducing powerful psychoactive compounds into the human body routinely engages complex, ancient regulatory systems.

Funding for the study was provided by Oregon State University, the OSU Center for the Humanities, and the OSU College of Liberal Arts. As research groups around the world build upon these baseline measurements, the scientific community moves one step closer to mapping the full physiological footprint of the modern cannabis era.